ThermoGenesis Holdings competitors

Patrick Miles is a Chairman & CEO at Aphatec Spine and is based in San Diego, California. She has experience at Smith & Nephew and has worked as Chairman at ALPHATEC HOLDINGS, INC.; Exec VP:Product Mktg & Dev at NUVASIVE INC; and Board Member at NUVASIVE INC. Patrick studied at MERCER UNIVERSITY between 1984 and 1988.

Results-focused senior executive whose strategic vision, leadership and commitment to success consistently led to dynamic gains in revenue, profit, operational performance and competitive advantage in US and global markets. Leverages instinctive ability to zero in on product and market potential to achieve objectives in start-up, turnaround and growth environments.Selected Achievements:Led $400 million division to record growth in worldwide sales and profit, with 14% year-over-year revenue gains and 10 point improvement in the bottom line.Key member of executive team that negotiated the $2.2 billion acquisition of Gyrus ACMI by Olympus Corporation.Built US division to $96.6 million in sales with average annual revenue growth of 35% for 3 consecutive years.Strategic forward thinker - initiated and spearheaded a comprehensive $700 million business restructuring to comply with changing healthcare laws and regulations while concurrently streamlining process, driving productivity and increasing customer satisfaction. The initiative resulted in a 15% reduction in expenses and a 5% revenue increase.

John Onopchenko is a Board Member at Synecor, Board Member at Endologix Inc, and Chief Executive Officer at Endologix Inc. He has worked as Chief Operating Officer at VOLCANO CO., LTD.; Chief Operating Officer at Endologix Inc; and Exec VP:Strategy at VOLCANO CO., LTD.. John works or has worked as VP:Venture Investments at Johnson & Johnson Innovation - Jjdc Inc, Managing Director/Gen Partner at Synergy Life Sciences Partners, and MEMBER at FINRA. He studied at University of Chicago Booth School of Business and Ursinus College.

Dr. Singh was elected President and Chief Executive Officer of PerkinElmer effective December 30, 2019, and appointed to our board of directors in August 2019. Previously Dr. Singh was the President and Chief Operating Officer of the Company since January 2019. Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014. He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare and Philips Healthcare. Earlier in his career, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol-Myers Squibb Medical Imaging, which included managing the Asia Pacific and Middle East region. Dr. Singh holds a doctoral degree in chemistry from the University of Missouri-Columbia and a Master of Business Administration from Northeastern University. His research work has resulted in several issued patents and publications in peer reviewed journals. Dr. Singh has more than twenty-five years of leadership experience with global innovators in healthcare technology. He has spent the most recent six years developing unique insights into both our business and our opportunities for continued growth. Dr. Singh brings to our board a detailed understanding of the core technologies that we utilize and the operational strategies available to us as we continue to focus on innovating for a healthier world.

Founder of The Chopra Foundation, a non-profit entity for research on well-being and humanitarianism, and Chopra Global, a whole health company at the intersection of science and spirituality, is a world-renowned pioneer in integrative medicine and personal transformation. Chopra is a Clinical Professor of Family Medicine and Public Health at the University of California, San Diego and serves as a senior scientist with Gallup Organization.

David Portnoy is a Chairman and Co-CEO at CRYO CELL INTERNATIONAL INC and is based in Miami/Fort Lauderdale Area. He studied at The Wharton School between 1981 and 1984.